Home » Clinical Trial Requirements Under Trans-Tasman Authority Outlined
Clinical Trial Requirements Under Trans-Tasman Authority Outlined
March 15, 2007
Details on conducting clinical trials under the proposed Australia New Zealand Therapeutic Products Authority (ANZTPA) are laid out in a new consultation paper released by the two countries’ current regulatory authorities.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor